CG
MRSN

Cutler Group’s Mersana Therapeutics MRSN Stock Holding History

Cutler Group’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Hold
0
– – – 4306
2023
Q2 		– Sell
-48
Closed -$7.02K – 4138
2023
Q1 		$4K Hold
48
– – ﹤0.01% 2848
2022
Q4 		$7K Hold
48
– – ﹤0.01% 2951
2022
Q3 		$8K Hold
48
– – ﹤0.01% 3292
2022
Q2 		$5K Hold
48
– – ﹤0.01% 3729
2022
Q1 		$4K Hold
48
– – ﹤0.01% 4297
2021
Q4 		$7K Hold
48
– – ﹤0.01% 3961
2021
Q3 		$11K Sell
48
-184
-79% -$53.8K ﹤0.01% 3850
2021
Q2 		$78K Buy
232
+88
+61% +$33.3K 0.01% 2089
2021
Q1 		$58K Buy
+144
New +$69.8K ﹤0.01% 2235
2020
Q4 		– Sell
-36
Closed -$20K – 5469
2020
Q3 		$16K Buy
+36
New +$18.2K ﹤0.01% 2643
2020
Q2 		– Sell
-8
Closed -$2.73K – 4941
2020
Q1 		$1K Buy
+8
New +$1.4K ﹤0.01% 3743

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return